Skip to content

Neurolutions

4 viewers · 30d

Total raised

$26.5M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $26.5M
ROUNDS
1
INVESTORS
9
FOUNDED
N/A
HQ
Van Nuys, CA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
4

AI overview

Updated

Neurolutions Inc. is a pioneering medical technology company committed to enhancing stroke rehabilitation through innovative solutions. With a focus on improving the quality of life for chronic stroke survivors, the company develops advanced therapeutic devices that utilize cutting-edge technology to facilitate recovery.

What sets it apart

Neurolutions stands out as the first company to receive FDA authorization for a brain-computer interface device specifically designed for stroke rehabilitation, enabling patients to regain mobility and function through thought-controlled therapy.

Funding history

1 round
EquityFeb 14, 2025
Form D
+$26.5M$26.5M total

Latest SEC filings

via EDGAR · CIK 0001450737
Form D · Feb 14, 2025View on EDGAR

Products

1 tracked

IpsiHand Upper Extremity Rehabilitation System

Rehabilitation Device

The IpsiHand Upper Extremity Rehabilitation System is a revolutionary therapeutic device that utilizes brain-computer interface technology to assist stroke patients in regaining hand and arm function. It is tailored to facilitate muscle re-education and improve mobility in patients with upper limb deficits resulting from chronic strokes.

  • Robotic handpiece worn on the patient's hand and wrist
  • EEG-based headset for detecting brain signals
  • Interactive tablet guiding therapy sessions

Links

WebsiteSEC EDGAR filings